Zobrazeno 1 - 6 of 6 pro vyhledávání: '"E B, DeSouza"'
1
Differential pharmacological profile of striatal and cerebellar dopamine receptors labeled by [3H]quinpirole: Identification of a discrete population of putative D3 receptors
Autor: Beth Levant, E B DeSouza
Publikováno v: Synapse. 14:90-95
We have previously identified [3H]quinpirole-labeled dopamine receptors in the molecular layer of cerebellar lobule 10 which have a D2-like pharmacological profile, are guanine nucleotide-insensitive, and are juxtaposed to putative D3 receptor mRNA.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aa3651334a7e69b43cfacda4d278c06
https://doi.org/10.1002/syn.890140112
Zobrazit plný text záznamu
2
[3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study
Autor: B, Levant, D E, Grigoriadis, E B, DeSouza
Publikováno v: The Journal of pharmacology and experimental therapeutics. 264(2)
The putative D2 dopamine receptor agonist quinpirole (LY 171,555) has been extensively used in a variety of in vivo and in vitro studies of D2 receptor-mediated effects and may have even higher affinity for the recently described D3 dopamine receptor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c21ab4ed255a8335c23a70896425b543
https://pubmed.ncbi.nlm.nih.gov/8437136
Zobrazit plný text záznamu
3
Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain
Autor: B, Levant, D E, Grigoriadis, E B, DeSouza
Publikováno v: The Journal of pharmacology and experimental therapeutics. 262(3)
The putative D2 dopamine receptor agonist quinpirole (LY 171,555) is the most widely used D2 agonist in in vivo and in vitro studies of D2 receptor-mediated effects. In addition, quinpirole may have even higher affinity for the recently described D3
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d391fd2a8a78435b73d5d224e3fd4734
https://pubmed.ncbi.nlm.nih.gov/1356154
Zobrazit plný text záznamu
4
Diabetes-related changes in brain beta adrenoreceptors in rats as assessed by quantitative autoradiography: relationship to hypothalamic norepinephrine metabolism and pituitary-gonadal hormone secretion
Autor: M S, Bitar, E B, DeSouza
Publikováno v: The Journal of pharmacology and experimental therapeutics. 254(3)
Streptozotocin (STZ)-induced diabetes produced significant and selective alterations in brain beta adrenoreceptor subtypes, norepinephrine (NE) metabolism and pituitary-testicular hormone in male rats. The densities of beta-1 but not beta-2 adrenorec
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f4777d0290007bea1826305196bea1e4
https://pubmed.ncbi.nlm.nih.gov/2168485
Zobrazit plný text záznamu
5
Immunohistochemical study of neurons containing corticotropin-releasing factor in Alzheimer's disease
Autor: Donald L. Price, E. B. DeSouza, Peter J. Whitehouse, Richard E. Powers, Robert G. Struble, Lary C. Walker, W. W. Vale
Publikováno v: Synapse. 1:405-410
In the brains of controls and individuals with Alzheimer's disease (AD), antisera to corticotropin-releasing factor (CRF) were used to immunostain neurons and their processes. In AD, we identified abnormal CRF-immunoreactive axons as well as neurites
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2298331226d8c05fdd6d8d8ae80e3a98
https://doi.org/10.1002/syn.890010504
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje